Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review

Cancer initiation and progression have been associated with dysregulated long non‐coding RNA (lncRNA) expression. However, the lncRNA expression profile in aggressive B‐cell non‐Hodgkin lymphoma (NHL) has not been comprehensively characterized. This systematic review aims to evaluate the role of lnc...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular and molecular medicine Vol. 27; no. 14; pp. 1928 - 1946
Main Authors Khanmohammadi, Shaghayegh, Fallahtafti, Parisa
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.07.2023
John Wiley and Sons Inc
Subjects
Adult
aggressive non‐Hodgkin lymphoma
Apoptosis
B-cell lymphoma
biomarker
Biomarkers
Burkitt Lymphoma - drug therapy
Burkitt's lymphoma
Cell cycle
Cell migration
Cell proliferation
Chemotherapy
Cyclin-dependent kinases
Diagnosis
diffuse large B‐cell lymphoma
Epigenetics
Growth factors
Humans
Kinases
Leukemia
long non‐coding RNA
Lymphocytes
Lymphocytes B
Lymphoma
Lymphoma, Large B-Cell, Diffuse - diagnosis
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoma, Large B-Cell, Diffuse - genetics
Lymphoma, Mantle-Cell
Mantle cell lymphoma
Non-coding RNA
Non-Hodgkin's lymphoma
non‐Hodgkin lymphomas
Pathogenesis
Prognosis
Proteins
Review
Reviews
RNA, Long Noncoding - genetics
Systematic review
Therapeutic applications
Therapeutic targets
non-Hodgkin lymphomas
aggressive non-Hodgkin lymphoma
mantle cell lymphoma
long non-coding RNA
diffuse large B-cell lymphoma
biomarker
Burkitt's lymphoma
Online AccessGet full text

Cover

Abstract Cancer initiation and progression have been associated with dysregulated long non‐coding RNA (lncRNA) expression. However, the lncRNA expression profile in aggressive B‐cell non‐Hodgkin lymphoma (NHL) has not been comprehensively characterized. This systematic review aims to evaluate the role of lncRNAs as a biomarker to investigate their future potential in the diagnosis, real‐time measurement of response to therapy and prognosis in aggressive B‐cell NHL. We searched PubMed, Web of Science, Embase and Scopus databases using the keywords “long non‐coding RNA”, “Diffuse large B‐cell lymphoma”, “Burkitt's lymphoma” and “Mantle cell lymphoma”. We included studies on human subjects that measured the level of lncRNAs in samples from patients with aggressive B‐cell NHL. We screened 608 papers, and 51 papers were included. The most studied aggressive B‐cell NHL was diffuse large B‐cell lymphoma (DLBCL). At least 79 lncRNAs were involved in the pathogenesis of aggressive B‐cell NHL. Targeting lncRNAs could affect cell proliferation, viability, apoptosis, migration and invasion in aggressive B‐cell NHL cell lines. Dysregulation of lncRNAs had prognostic (e.g. overall survival) and diagnostic values in patients with DLBCL, Burkitt's lymphoma (BL), or mantle cell lymphoma (MCL). Furthermore, dysregulation of lncRNAs was associated with response to treatments, such as CHOP‐like chemotherapy regimens, in these patients. LncRNAs could be promising biomarkers for the diagnosis, prognosis and response to therapy in patients with aggressive B‐cell NHL. Additionally, lncRNAs could be potential therapeutic targets for patients with aggressive B‐cell NHL like DLBCL, MCL or BL.
AbstractList Cancer initiation and progression have been associated with dysregulated long non-coding RNA (lncRNA) expression. However, the lncRNA expression profile in aggressive B-cell non-Hodgkin lymphoma (NHL) has not been comprehensively characterized. This systematic review aims to evaluate the role of lncRNAs as a biomarker to investigate their future potential in the diagnosis, real-time measurement of response to therapy and prognosis in aggressive B-cell NHL. We searched PubMed, Web of Science, Embase and Scopus databases using the keywords "long non-coding RNA", "Diffuse large B-cell lymphoma", "Burkitt's lymphoma" and "Mantle cell lymphoma". We included studies on human subjects that measured the level of lncRNAs in samples from patients with aggressive B-cell NHL. We screened 608 papers, and 51 papers were included. The most studied aggressive B-cell NHL was diffuse large B-cell lymphoma (DLBCL). At least 79 lncRNAs were involved in the pathogenesis of aggressive B-cell NHL. Targeting lncRNAs could affect cell proliferation, viability, apoptosis, migration and invasion in aggressive B-cell NHL cell lines. Dysregulation of lncRNAs had prognostic (e.g. overall survival) and diagnostic values in patients with DLBCL, Burkitt's lymphoma (BL), or mantle cell lymphoma (MCL). Furthermore, dysregulation of lncRNAs was associated with response to treatments, such as CHOP-like chemotherapy regimens, in these patients. LncRNAs could be promising biomarkers for the diagnosis, prognosis and response to therapy in patients with aggressive B-cell NHL. Additionally, lncRNAs could be potential therapeutic targets for patients with aggressive B-cell NHL like DLBCL, MCL or BL.Cancer initiation and progression have been associated with dysregulated long non-coding RNA (lncRNA) expression. However, the lncRNA expression profile in aggressive B-cell non-Hodgkin lymphoma (NHL) has not been comprehensively characterized. This systematic review aims to evaluate the role of lncRNAs as a biomarker to investigate their future potential in the diagnosis, real-time measurement of response to therapy and prognosis in aggressive B-cell NHL. We searched PubMed, Web of Science, Embase and Scopus databases using the keywords "long non-coding RNA", "Diffuse large B-cell lymphoma", "Burkitt's lymphoma" and "Mantle cell lymphoma". We included studies on human subjects that measured the level of lncRNAs in samples from patients with aggressive B-cell NHL. We screened 608 papers, and 51 papers were included. The most studied aggressive B-cell NHL was diffuse large B-cell lymphoma (DLBCL). At least 79 lncRNAs were involved in the pathogenesis of aggressive B-cell NHL. Targeting lncRNAs could affect cell proliferation, viability, apoptosis, migration and invasion in aggressive B-cell NHL cell lines. Dysregulation of lncRNAs had prognostic (e.g. overall survival) and diagnostic values in patients with DLBCL, Burkitt's lymphoma (BL), or mantle cell lymphoma (MCL). Furthermore, dysregulation of lncRNAs was associated with response to treatments, such as CHOP-like chemotherapy regimens, in these patients. LncRNAs could be promising biomarkers for the diagnosis, prognosis and response to therapy in patients with aggressive B-cell NHL. Additionally, lncRNAs could be potential therapeutic targets for patients with aggressive B-cell NHL like DLBCL, MCL or BL.
Cancer initiation and progression have been associated with dysregulated long non‐coding RNA (lncRNA) expression. However, the lncRNA expression profile in aggressive B‐cell non‐Hodgkin lymphoma (NHL) has not been comprehensively characterized. This systematic review aims to evaluate the role of lncRNAs as a biomarker to investigate their future potential in the diagnosis, real‐time measurement of response to therapy and prognosis in aggressive B‐cell NHL. We searched PubMed, Web of Science, Embase and Scopus databases using the keywords “long non‐coding RNA”, “Diffuse large B‐cell lymphoma”, “Burkitt's lymphoma” and “Mantle cell lymphoma”. We included studies on human subjects that measured the level of lncRNAs in samples from patients with aggressive B‐cell NHL. We screened 608 papers, and 51 papers were included. The most studied aggressive B‐cell NHL was diffuse large B‐cell lymphoma (DLBCL). At least 79 lncRNAs were involved in the pathogenesis of aggressive B‐cell NHL. Targeting lncRNAs could affect cell proliferation, viability, apoptosis, migration and invasion in aggressive B‐cell NHL cell lines. Dysregulation of lncRNAs had prognostic (e.g. overall survival) and diagnostic values in patients with DLBCL, Burkitt's lymphoma (BL), or mantle cell lymphoma (MCL). Furthermore, dysregulation of lncRNAs was associated with response to treatments, such as CHOP‐like chemotherapy regimens, in these patients. LncRNAs could be promising biomarkers for the diagnosis, prognosis and response to therapy in patients with aggressive B‐cell NHL. Additionally, lncRNAs could be potential therapeutic targets for patients with aggressive B‐cell NHL like DLBCL, MCL or BL.
Author Khanmohammadi, Shaghayegh
Fallahtafti, Parisa
AuthorAffiliation 2 Non‐Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran
3 School of Medicine Tehran University of Medical Sciences Tehran Iran
1 Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Tehran University of Medical Sciences Tehran Iran
AuthorAffiliation_xml – name: 2 Non‐Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran
– name: 1 Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Tehran University of Medical Sciences Tehran Iran
– name: 3 School of Medicine Tehran University of Medical Sciences Tehran Iran
Author_xml – sequence: 1
  givenname: Shaghayegh
  orcidid: 0000-0002-8732-0191
  surname: Khanmohammadi
  fullname: Khanmohammadi, Shaghayegh
  email: shaghayegh.khanmohammadi@gmail.com
  organization: Tehran University of Medical Sciences
– sequence: 2
  givenname: Parisa
  surname: Fallahtafti
  fullname: Fallahtafti, Parisa
  organization: Tehran University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37246627$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu1DAUhi1URC-w4QGQJTYV0pQ4TjI2GzQdUQqagoRgbTnOmYyniT3YyVSz66b7PgLPwqPwJJwwQwUVwhvfvvPJx_8h2XPeASFPWXLCcLxcmrY9YeOxzB-QA5aLdJRJnu3t1kxwsU8OY1wmCS8Yl4_IPh-nWVGk4wNyM_Oupij8cX1rfGVx8-nDhOpINZ6uoaGl9a0OlxCodhXtFhD0CvrOGtrpUENHraO6rgPEaNdATwcRNM3Oee6r-hKJZtOuFih6RSffv8VN7KDVgyPA2sLVY_JwrpsIT3bzEfly9ubz9Hw0-_j23XQyG5ksk_kI0lRLLkHkUGpdlMKISoDkYp7K-XCuWckSDiwT2gDjlWQZfktSlSB1VhX8iLzeeld92UJlwHVBN2oVLLa4UV5b9feNswtV-7VCK5eJlGg43hmC_9pD7FRr49CvduD7qFKRIlrwnCH6_B669H1w2B9SmEQuCzYIn_35pLu3_I4IgRdbwAQfY4D5HcISNeSvhvzVr_wRTu7Bxnb40X5oxzb_LmHbkivbwOY_cvV-enGxrfkJOBLIZQ
CitedBy_id crossref_primary_10_1111_ijlh_14440
crossref_primary_10_1038_s41375_024_02344_1
crossref_primary_10_1002_cnr2_70070
crossref_primary_10_1111_jcmm_18109
crossref_primary_10_1371_journal_pone_0308009
crossref_primary_10_1515_revneuro_2023_0155
crossref_primary_10_1016_j_gene_2024_148480
crossref_primary_10_3390_ijms252111384
crossref_primary_10_1186_s12935_023_03113_3
crossref_primary_10_1016_j_genrep_2025_102182
Cites_doi 10.2147/CMAR.S248698
10.1007/s13577-022-00725-1
10.1016/j.yexmp.2020.104451
10.3892/or.2020.7897
10.1002/cac2.12108
10.1155/2017/7243968
10.3390/cells9020276
10.1016/S0140-6736(16)32407-2
10.1016/j.arcmed.2022.01.004
10.1093/abbs/gmz114
10.2147/CMAR.S284258
10.1371/journal.pone.0105382
10.1093/carcin/bgab013
10.1007/s10238-015-0396-8
10.7150/ijms.51329
10.18632/oncotarget.17303
10.3324/haematol.2020.274258
10.18632/oncotarget.20053
10.1016/j.critrevonc.2019.05.007
10.3390/cells11213394
10.1371/journal.pone.0138236
10.7150/jca.60521
10.1080/08923973.2022.2052896
10.1016/j.lfs.2019.03.040
10.3892/ijo.2021.5274
10.1007/s13273-022-00237-x
10.1007/978-981-10-5203-3_1
10.1002/hon.3004
10.1016/j.lfs.2021.119932
10.1038/s41419-019-1479-3
10.2147/OTT.S249429
10.1186/s12935-020-1158-6
10.1002/jcla.24168
10.1038/s41419-019-1886-5
10.3892/etm.2022.11564
10.1042/EBC20200032
10.1007/s10552-019-01155-5
10.18632/oncotarget.15711
10.1016/j.cca.2019.04.082
10.1016/j.transci.2013.05.029
10.1016/j.biopha.2015.12.001
10.1158/0008-5472.CAN-10-2483
10.1080/10428194.2021.1876866
10.1371/journal.pmed.1000097
10.1038/cr.2014.165
10.1002/cbin.11327
10.18632/oncotarget.17956
10.1038/onc.2017.184
10.3892/ol.2020.12300
10.1073/pnas.242606799
10.1002/jcla.24680
10.1016/j.bbrc.2019.01.105
10.1007/s10238-015-0350-9
10.1002/jbt.22768
10.1038/s41417-020-00267-4
10.1016/j.biopha.2017.02.011
10.1007/s11010-021-04335-7
10.1073/pnas.1505753112
10.1186/s12967-016-1100-9
10.18632/oncotarget.15571
10.12659/MSM.912141
10.3892/mmr.2016.5190
10.1056/NEJMra0807082
10.1016/j.humgen.2022.201112
10.12659/MSM.922810
10.1007/s10238-021-00748-2
10.1111/jcmm.14601
10.2147/CMAR.S233859
10.1007/s00335-021-09939-4
10.1038/s41420-022-00819-7
10.1093/biohorizons/hzt006
10.1248/yakushi.20-00002
10.1038/s41392-023-01342-6
10.3389/fimmu.2022.813031
10.1016/j.biopha.2016.02.032
10.3892/or.2017.5821
10.18632/oncotarget.16163
10.1038/s41598-021-81715-5
10.3233/CBM-160221
ContentType Journal Article
Copyright 2023 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
– notice: 2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7TK
7X7
7XB
88E
88I
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
5PM
DOI 10.1111/jcmm.17795
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

MEDLINE

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Khanmohammadi and Fallahtafti
EISSN 1582-4934
EndPage 1946
ExternalDocumentID PMC10339099
37246627
10_1111_jcmm_17795
JCMM17795
Genre reviewArticle
Systematic Review
Journal Article
GroupedDBID ---
0R~
1OC
24P
29K
31~
36B
3V.
4.4
53G
5GY
5VS
7X7
8-0
8-1
88E
88I
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AAHHS
AAZKR
ABUWG
ACCFJ
ACCMX
ACGFS
ACGOD
ACXQS
ADBBV
ADKYN
ADPDF
ADRAZ
ADZMN
ADZOD
AEEZP
AENEX
AEQDE
AFBPY
AFKRA
AFZJQ
AHMBA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
D-9
D-I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
EMB
EMOBN
F5P
FYUFA
GNUQQ
GODZA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
IAO
IHR
ITC
KQ8
LH4
LK8
LW6
M1P
M2P
M48
M7P
O9-
OIG
OK1
OVD
OVEED
PIMPY
PQQKQ
PROAC
PSQYO
Q2X
RNS
ROL
RPM
SV3
TEORI
UKHRP
WIN
AAYXX
ABJNI
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7QP
7TK
7XB
8FD
8FK
FR3
K9.
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
RC3
7X8
5PM
ID FETCH-LOGICAL-c4495-e22a939e85ebaa6b8c8d8e938f29f39e8a1b103e148ace13d9147790dbe9a4d63
IEDL.DBID 7X7
ISSN 1582-1838
1582-4934
IngestDate Thu Aug 21 18:36:48 EDT 2025
Fri Jul 11 07:41:34 EDT 2025
Wed Aug 13 07:25:49 EDT 2025
Mon Jul 21 05:57:41 EDT 2025
Tue Jul 01 01:35:22 EDT 2025
Thu Apr 24 22:57:11 EDT 2025
Wed Jan 22 16:21:43 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Keywords non-Hodgkin lymphomas
aggressive non-Hodgkin lymphoma
mantle cell lymphoma
long non-coding RNA
diffuse large B-cell lymphoma
biomarker
Burkitt's lymphoma
Language English
License Attribution
2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4495-e22a939e85ebaa6b8c8d8e938f29f39e8a1b103e148ace13d9147790dbe9a4d63
Notes Shaghayegh Khanmohammadi and Parisa Fallahtafti contributed equally to this work.
ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
ObjectType-Review-4
content type line 23
ORCID 0000-0002-8732-0191
OpenAccessLink https://www.proquest.com/docview/2836159619?pq-origsite=%requestingapplication%
PMID 37246627
PQID 2836159619
PQPubID 2034150
PageCount 19
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10339099
proquest_miscellaneous_2820336351
proquest_journals_2836159619
pubmed_primary_37246627
crossref_primary_10_1111_jcmm_17795
crossref_citationtrail_10_1111_jcmm_17795
wiley_primary_10_1111_jcmm_17795_JCMM17795
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2023
PublicationDateYYYYMMDD 2023-07-01
PublicationDate_xml – month: 07
  year: 2023
  text: July 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
– name: Hoboken
PublicationTitle Journal of cellular and molecular medicine
PublicationTitleAlternate J Cell Mol Med
PublicationYear 2023
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2021; 25
2017; 8
2021; 65
2019; 51
2020; 20
2019; 10
2023; 8
2021; 28
2017; 89
2002; 99
2020; 17
2022; 24
2017; 390
2019; 18
2020; 13
2020; 12
2022; 22
2021; 286
2013; 6
2016; 79
2016; 77
2021; 35
2000
2017; 36
2022; 40
2017; 38
2011; 71
2019; 23
2019; 25
2020; 9
2022; 34
2022; 35
2022; 36
2019; 510
2020; 44
2022; 33
2014; 9
2021; 41
2021; 2021
2019; 231
2021; 42
2021; 45
2013; 49
2017; 2017
2020; 140
2019; 30
2023; 19
2015; 10
2010; 362
2017; 1008
2022; 44
2018; 23
2019; 141
2016; 16
2016; 14
2016; 13
2022; 477
2021; 13
2015; 25
2021; 59
2021; 12
2021; 11
2022
2017; 17
2022; 8
2015; 112
2020; 115
2022; 13
2020; 26
2009; 6
2022; 53
2020; 21
2022; 11
2017; 102
2022; 107
2021; 62
2019; 495
e_1_2_9_75_1
e_1_2_9_31_1
e_1_2_9_50_1
e_1_2_9_73_1
e_1_2_9_79_1
Sapkota S (e_1_2_9_2_1) 2022
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_77_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_54_1
e_1_2_9_71_1
Li Y (e_1_2_9_56_1) 2021; 2021
e_1_2_9_14_1
e_1_2_9_39_1
Wells GA (e_1_2_9_16_1) 2000
e_1_2_9_37_1
e_1_2_9_58_1
e_1_2_9_18_1
Gao H (e_1_2_9_80_1) 2021; 12
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_87_1
e_1_2_9_62_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_83_1
Fan Z (e_1_2_9_60_1) 2019; 18
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_85_1
e_1_2_9_8_1
Gao H (e_1_2_9_20_1) 2017; 102
e_1_2_9_81_1
e_1_2_9_4_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_74_1
e_1_2_9_51_1
e_1_2_9_72_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_78_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_76_1
e_1_2_9_70_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_63_1
e_1_2_9_88_1
e_1_2_9_40_1
e_1_2_9_61_1
e_1_2_9_21_1
e_1_2_9_46_1
e_1_2_9_67_1
e_1_2_9_84_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_65_1
e_1_2_9_86_1
e_1_2_9_7_1
e_1_2_9_5_1
e_1_2_9_82_1
e_1_2_9_3_1
Tian M (e_1_2_9_52_1) 2021; 25
Ahmad P (e_1_2_9_6_1) 2021; 11
e_1_2_9_9_1
e_1_2_9_25_1
e_1_2_9_27_1
e_1_2_9_48_1
e_1_2_9_69_1
e_1_2_9_29_1
References_xml – volume: 8
  start-page: 71
  issue: 1
  year: 2023
  article-title: Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
  publication-title: Signal Transduct Target Ther
– volume: 79
  start-page: 188
  year: 2016
  end-page: 193
  article-title: Long noncoding RNA HULC predicts poor clinical outcome and represents pro‐oncogenic activity in diffuse large B‐cell lymphoma
  publication-title: Biomed Pharmacother
– volume: 33
  start-page: 328
  issue: 2
  year: 2022
  end-page: 342
  article-title: Genomic and functional conservation of lncRNAs: lessons from flies
  publication-title: Mamm Genome
– volume: 10
  start-page: 731
  issue: 10
  year: 2019
  article-title: LncRNA SNHG14/miR‐5590‐3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD‐1/PD‐L1 checkpoint
  publication-title: Cell Death Dis
– volume: 10
  issue: 9
  year: 2015
  article-title: Long noncoding RNA expression during human B‐cell development
  publication-title: PLoS One
– volume: 53
  start-page: 271
  issue: 3
  year: 2022
  end-page: 279
  article-title: LncRNA NORAD mediates the proliferation and apoptosis of diffuse large‐B‐cell lymphoma via regulation of miR‐345‐3p/TRAF6 axis
  publication-title: Arch Med Res
– volume: 59
  start-page: 1
  issue: 5
  year: 2021
  end-page: 12
  article-title: lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis
  publication-title: Int J Oncol
– volume: 14
  start-page: 346
  issue: 1
  year: 2016
  article-title: LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
  publication-title: J Transl Med
– volume: 12
  start-page: 5845
  year: 2020
  end-page: 5855
  article-title: Knockdown of lncRNA MCM3AP‐AS1 attenuates chemoresistance of Burkitt lymphoma to doxorubicin treatment via targeting the miR‐15a/EIF4e axis
  publication-title: Cancer Manag Res
– volume: 6
  start-page: hzt006
  year: 2013
  article-title: Preliminary investigation of the effects of silencing the non‐coding RNA, NEAT1, on the Burkitt's lymphoma cell line BJAB
  publication-title: Biosci Horiz
– volume: 51
  start-page: 1142
  issue: 11
  year: 2019
  end-page: 1147
  article-title: Downregulation of MANCR inhibits cancer cell proliferation in mantle cell lymphoma possibly by interacting with RUNX2
  publication-title: Acta Biochim Biophys Sin
– volume: 141
  start-page: 13
  year: 2019
  end-page: 22
  article-title: Role of long non‐coding RNAs in lymphoma: a systematic review and clinical perspectives
  publication-title: Crit Rev Oncol Hematol
– volume: 13
  start-page: 5125
  issue: 6
  year: 2016
  end-page: 5131
  article-title: Elevated RNA expression of long non‐coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma
  publication-title: Mol Med Rep
– volume: 23
  start-page: 157
  issue: 2
  year: 2018
  end-page: 164
  article-title: Aberrant NEAT1‐1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma
  publication-title: Cancer Biomark
– volume: 11
  start-page: 2095
  issue: 1
  year: 2021
  article-title: Circulating long non‐coding RNAs HOTAIR, Linc‐p21, GAS5 and XIST expression profiles in diffuse large B‐cell lymphoma: association with R‐CHOP responsiveness
  publication-title: Sci Rep
– volume: 8
  start-page: 80223
  issue: 46
  year: 2017
  end-page: 80234
  article-title: Long non‐coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1‐AS1 associated with EZH2/PRC2 complex
  publication-title: Oncotarget
– volume: 77
  start-page: 65
  year: 2016
  end-page: 71
  article-title: Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B‐cell lymphoma
  publication-title: Biomed Pharmacother
– volume: 45
  start-page: 469
  issue: 2
  year: 2021
  end-page: 480
  article-title: LncRNA FOXP4‐AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR‐423‐5p/NACC1 pathway
  publication-title: Oncol Rep
– volume: 25
  start-page: 2567
  issue: 6
  year: 2021
  end-page: 2576
  article-title: LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR‐508‐3p/NFIB axis in diffuse large B‐cell lymphoma
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 510
  start-page: 594
  issue: 4
  year: 2019
  end-page: 600
  article-title: LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B‐cell lymphoma via Wnt/β‐catenin signaling pathway
  publication-title: Biochem Biophys Res Commun
– volume: 18
  start-page: 2443
  issue: 3
  year: 2019
  end-page: 2447
  article-title: Overexpression of lncRNA GATA6‐AS inhibits cancer cell proliferation in mantle cell lymphoma by downregulating GLUT1
  publication-title: Oncol Lett
– volume: 42
  start-page: 733
  issue: 5
  year: 2021
  end-page: 741
  article-title: LINC00857 contributes to proliferation and lymphomagenesis by regulating miR‐370‐3p/CBX3 axis in diffuse large B‐cell lymphoma
  publication-title: Carcinogenesis
– volume: 477
  start-page: 951
  issue: 3
  year: 2022
  end-page: 963
  article-title: LncRNA PVT1 facilitates DLBCL development via miR‐34b‐5p/Foxp1 pathway
  publication-title: Mol Cell Biochem
– volume: 99
  start-page: 15524
  issue: 24
  year: 2002
  end-page: 15529
  article-title: Frequent deletions and down‐regulation of micro‐ RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
  publication-title: Proc Natl Acad Sci U S A
– volume: 12
  start-page: 8225
  issue: 12
  year: 2021
  end-page: 8246
  article-title: Long non‐coding RNA AFAP1‐AS1 promotes cell growth and inhibits apoptosis by binding to specific proteins in germinal center B‐cell‐like diffuse large B‐cell lymphoma
  publication-title: Am J Transl Res
– volume: 362
  start-page: 1417
  issue: 15
  year: 2010
  end-page: 1429
  article-title: Aggressive lymphomas
  publication-title: N Engl J Med
– volume: 140
  start-page: 687
  issue: 5
  year: 2020
  end-page: 700
  article-title: Non‐coding natural antisense RNA: mechanisms of action in the regulation of target gene expression and its clinical implications
  publication-title: Yakugaku Zasshi
– volume: 9
  start-page: 276
  issue: 2
  year: 2020
  article-title: miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis
  publication-title: Cells
– volume: 2021
  start-page: 1
  year: 2021
  end-page: 11
  article-title: TUC338 promotes diffuse large B cell lymphoma growth via regulating EGFR/PI3K/AKT signaling pathway
  publication-title: J Oncol
– volume: 115
  year: 2020
  article-title: FOXM1‐induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B‐cell lymphoma via Wnt/β‐catenin signaling pathway
  publication-title: Exp Mol Pathol
– volume: 35
  start-page: 1
  issue: 6
  year: 2021
  end-page: 12
  article-title: A 6‐lncRNA signature predicts prognosis of diffuse large B‐cell lymphoma
  publication-title: J Biochem Mol Toxicol
– year: 2022
– volume: 36
  issue: 1
  year: 2022
  article-title: Long non‐coding RNA HAGLROS promotes the development of diffuse large B‐cell lymphoma via suppressing miR‐100
  publication-title: J Clin Lab Anal
– volume: 25
  start-page: 365
  year: 2019
  end-page: 370
  article-title: LINK‐A lncRNA promotes proliferation and inhibits apoptosis of mantle cell lymphoma cell by upregulating survivin
  publication-title: Med Sci Monit
– volume: 112
  start-page: E5261
  issue: 38
  year: 2015
  end-page: E5270
  article-title: MINCR is a MYC‐induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells
  publication-title: Proc Natl Acad Sci U S A
– volume: 13
  start-page: 784
  issue: 3
  year: 2022
  end-page: 792
  article-title: LncRNA SNHG5 can regulate the proliferation and migration of diffuse large B cell lymphoma progression via targeting miR‐181‐5p/XIAP
  publication-title: J Cancer
– volume: 11
  start-page: 3394
  issue: 21
  year: 2022
  article-title: Whole transcriptome sequencing reveals cancer‐related, prognostically significant transcripts and tumor‐infiltrating immunocytes in mantle cell lymphoma
  publication-title: Cell
– volume: 107
  start-page: 690
  issue: 3
  year: 2022
  end-page: 701
  article-title: Subtype‐specific and co‐occurring genetic alterations in B‐cell non‐Hodgkin lymphoma
  publication-title: Haematologica
– volume: 390
  start-page: 298
  issue: 10091
  year: 2017
  end-page: 310
  article-title: Non‐Hodgkin lymphoma
  publication-title: Lancet
– volume: 36
  issue: 10
  year: 2022
  article-title: LncRNA OR2A1‐AS1 index predicts survival in germinal center‐like diffuse large B‐cell lymphoma
  publication-title: J Clin Lab Anal
– volume: 24
  start-page: 627
  issue: 4
  year: 2022
  article-title: Knockdown of the long non‐coding RNA CACNA1G‐AS1 enhances cytotoxicity and apoptosis of human diffuse large B cell lymphoma by regulating miR‐3160‐5p
  publication-title: Exp Ther Med
– volume: 13
  start-page: 5563
  year: 2020
  end-page: 5574
  article-title: Long noncoding RNA SNHG12 indicates the prognosis and accelerates tumorigenesis of diffuse large B‐cell lymphoma through sponging microR‐195
  publication-title: Onco Targets Ther
– volume: 10
  start-page: 252
  issue: 4
  year: 2019
  article-title: Lnc SMAD5‐AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β‐catenin pathway by sponging miR‐135b‐5p to elevate expression of APC
  publication-title: Cell Death Dis
– volume: 8
  start-page: 60605
  issue: 36
  year: 2017
  end-page: 60623
  article-title: Long non‐coding RNAs in B‐cell malignancies: a comprehensive overview
  publication-title: Oncotarget
– volume: 231
  year: 2019
  article-title: LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR‐195
  publication-title: Life Sci
– volume: 30
  start-page: 489
  issue: 5
  year: 2019
  end-page: 499
  article-title: Global patterns and trends in the incidence of non‐Hodgkin lymphoma
  publication-title: Cancer Causes Control
– volume: 8
  start-page: 72182
  issue: 42
  year: 2017
  end-page: 72196
  article-title: Discovery and validation of the tumor‐suppressive function of long noncoding RNA PANDA in human diffuse large B‐cell lymphoma through the inactivation of MAPK/ERK signaling pathway
  publication-title: Oncotarget
– volume: 62
  start-page: 1574
  issue: 7
  year: 2021
  end-page: 1584
  article-title: lncRNA SNHG14 promotes oncogenesis and immune evasion in diffuse large‐B‐cell lymphoma by sequestering miR‐152‐3p
  publication-title: Leuk Lymphoma
– volume: 286
  year: 2021
  article-title: PAX5‐activated lncRNA ARRDC1‐AS1 accelerates the autophagy and progression of DLBCL through sponging miR‐2355‐5p to regulate ATG5
  publication-title: Life Sci
– volume: 8
  start-page: 27839
  issue: 17
  year: 2017
  end-page: 27853
  article-title: The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL
  publication-title: Oncotarget
– volume: 22
  start-page: 183
  issue: 2
  year: 2022
  end-page: 191
  article-title: Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B‐cell lymphoma
  publication-title: Clin Exp Med
– volume: 6
  issue: 7
  year: 2009
  article-title: Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement
  publication-title: PLoS Med
– year: 2000
– volume: 9
  issue: 8
  year: 2014
  article-title: Copy number variation analysis on a non‐Hodgkin lymphoma case‐control study identifies an 11q25 duplication associated with diffuse large B‐cell Lymphoma
  publication-title: PLoS One
– volume: 71
  start-page: 3
  issue: 1
  year: 2011
  end-page: 7
  article-title: Long intergenic noncoding RNAs: new links in cancer progression
  publication-title: Cancer Res
– volume: 49
  start-page: 72
  issue: 1
  year: 2013
  end-page: 79
  article-title: Relapsed and refractory aggressive NHL: time for a change
  publication-title: Transfus Apher Sci
– volume: 44
  start-page: 429
  issue: 3
  year: 2022
  end-page: 436
  article-title: LncRNA NEAT1 regulate diffuse large B‐cell lymphoma by targeting miR‐495‐3p/PD‐L1 axis
  publication-title: Immunopharmacol Immunotoxicol
– volume: 17
  start-page: 1
  issue: 1
  year: 2017
  end-page: 8
  article-title: LincRNA‐p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R‐CHOP chemotherapy
  publication-title: Clin Exp Med
– volume: 2017
  year: 2017
  article-title: Long noncoding RNAs as biomarkers in cancer
  publication-title: Dis Markers
– volume: 23
  start-page: 7395
  issue: 11
  year: 2019
  end-page: 7405
  article-title: Long non‐coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B‐cell lymphoma cells by targeting miR‐497‐5p/PIM1 axis
  publication-title: J Cell Mol Med
– volume: 25
  start-page: 80
  issue: 1
  year: 2015
  end-page: 92
  article-title: The p53‐induced lincRNA‐p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters
  publication-title: Cell Res
– volume: 21
  start-page: 39
  issue: 1
  year: 2020
  article-title: Knockdown of UCA1 restrains cell proliferation and metastasis of diffuse large B‐cell lymphoma by counteracting miR‐331‐3p expression
  publication-title: Oncol Lett
– volume: 1008
  start-page: 1
  year: 2017
  end-page: 46
  article-title: History, discovery, and classification of lncRNAs
  publication-title: Adv Exp Med Biol
– volume: 495
  start-page: 331
  year: 2019
  end-page: 337
  article-title: Liquid biopsy: circulating exosomal long noncoding RNAs in cancer
  publication-title: Clin Chim Acta
– volume: 8
  start-page: 34374
  issue: 21
  year: 2017
  end-page: 34386
  article-title: The long non‐coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B‐cell lymphoma
  publication-title: Oncotarget
– volume: 16
  start-page: 177
  issue: 2
  year: 2016
  end-page: 182
  article-title: Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity
  publication-title: Clin Exp Med
– volume: 26
  year: 2020
  article-title: Long non‐coding RNA paternally expressed imprinted gene 10 (PEG10) elevates diffuse large B‐cell lymphoma progression by regulating kinesin family member 2A (KIF2A) via targeting MiR‐101‐3p
  publication-title: Med Sci Monit
– volume: 34
  start-page: 201112
  year: 2022
  article-title: Biomedical impact of the expression of HOX locus‐associated LncRNAs HOTAIR and HOTTIP in diffuse large B cell lymphoma
  publication-title: Human Gene
– volume: 20
  start-page: 87
  issue: 1
  year: 2020
  article-title: MYC‐regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR‐34b‐5p‐GLI1 pathway in diffuse large B‐cell lymphoma
  publication-title: Cancer Cell Int
– volume: 12
  start-page: 2119
  year: 2020
  end-page: 2125
  article-title: LncRNA MORT inhibits cancer cell proliferation and promotes apoptosis in mantle cell lymphoma by upregulating miRNA‐16
  publication-title: Cancer Manag Res
– volume: 11
  start-page: 56
  issue: 1
  year: 2021
  article-title: Long non‐coding RNAs and their potential roles in the vector‐host‐pathogen triad
  publication-title: Life (Basel, Switzerland)
– volume: 36
  start-page: 5661
  issue: 41
  year: 2017
  end-page: 5667
  article-title: LncRNA‐mediated regulation of cell signaling in cancer
  publication-title: Oncogene
– volume: 35
  start-page: 1234
  issue: 4
  year: 2022
  end-page: 1247
  article-title: Long non‐coding RNA TRIM52‐AS1 sponges microRNA‐577 to facilitate diffuse large B cell lymphoma progression via increasing TRIM52 expression
  publication-title: Hum Cell
– volume: 13
  start-page: 813031
  year: 2022
  article-title: A 9‐LncRNA signature for predicting prognosis and immune response in diffuse large B‐cell lymphoma
  publication-title: Front Immunol
– volume: 8
  start-page: 25
  issue: 1
  year: 2022
  article-title: ALKBH5‐mediated N(6)‐methyladenosine modification of TRERNA1 promotes DLBCL proliferation via p21 downregulation
  publication-title: Cell Death Discov
– volume: 13
  start-page: 571
  year: 2021
  end-page: 578
  article-title: LncRNA SBF2‐AS1 promotes diffuse large B‐cell lymphoma growth by regulating FGFR2 via sponging miR‐494‐3p
  publication-title: Cancer Manag Res
– volume: 65
  start-page: 625
  issue: 4
  year: 2021
  end-page: 639
  article-title: Non‐coding RNA in cancer
  publication-title: Essays Biochem
– volume: 38
  start-page: 1363
  issue: 3
  year: 2017
  end-page: 1372
  article-title: Microarray expression profiles of long non‐coding RNAs in germinal center‐like diffuse large B‐cell lymphoma
  publication-title: Oncol Rep
– volume: 102
  start-page: 824
  year: 2017
  end-page: 825
  article-title: Microarray expression profile of long noncoding RNAS in germinal center‐like diffuse large B‐cell lymphoma
  publication-title: Haematologica
– volume: 41
  start-page: 109
  issue: 2
  year: 2021
  end-page: 120
  article-title: LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer
  publication-title: Cancer Commun
– volume: 89
  start-page: 939
  year: 2017
  end-page: 948
  article-title: The effects of the long non‐coding RNA MALAT‐1 regulated autophagy‐related signaling pathway on chemotherapy resistance in diffuse large B‐cell lymphoma
  publication-title: Biomed Pharmacother
– volume: 40
  start-page: 554
  issue: 4
  year: 2022
  end-page: 566
  article-title: LncRNA FIRRE stimulates PTBP1‐induced Smurf2 decay, stabilizes B‐cell receptor, and promotes the development of diffuse large B‐cell lymphoma
  publication-title: Hematol Oncol
– volume: 19
  start-page: 53
  issue: 1
  year: 2023
  end-page: 62
  article-title: LncRNA SNHG12/miR‐494‐3p/CBX3 axis in diffuse large B‐cell lymphoma
  publication-title: Mol Cell Toxicol
– volume: 44
  start-page: 1331
  issue: 6
  year: 2020
  end-page: 1340
  article-title: Long non‐coding RNA DBH‐AS1 promotes cancer progression in diffuse large B‐cell lymphoma by targeting FN1 via RNA‐binding protein BUD13
  publication-title: Cell Biol Int
– volume: 8
  start-page: 23228
  issue: 14
  year: 2017
  end-page: 23236
  article-title: Predictive analysis of long non‐coding RNA expression profiles in diffuse large B‐cell lymphoma
  publication-title: Oncotarget
– volume: 17
  start-page: 2735
  issue: 17
  year: 2020
  end-page: 2743
  article-title: Geniposide inhibits proliferation and induces apoptosis of diffuse large B‐cell lymphoma cells by inactivating the HCP5/miR‐27b‐3p/MET axis
  publication-title: Int J Med Sci
– volume: 28
  start-page: 1046
  issue: 9
  year: 2021
  end-page: 1057
  article-title: LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR‐141‐3p/MAP4K4 axis in diffuse large B‐cell lymphoma
  publication-title: Cancer Gene Ther
– volume: 12
  start-page: 8225
  issue: 12
  year: 2021
  ident: e_1_2_9_80_1
  article-title: Long non‐coding RNA AFAP1‐AS1 promotes cell growth and inhibits apoptosis by binding to specific proteins in germinal center B‐cell‐like diffuse large B‐cell lymphoma
  publication-title: Am J Transl Res
– volume: 18
  start-page: 2443
  issue: 3
  year: 2019
  ident: e_1_2_9_60_1
  article-title: Overexpression of lncRNA GATA6‐AS inhibits cancer cell proliferation in mantle cell lymphoma by downregulating GLUT1
  publication-title: Oncol Lett
– ident: e_1_2_9_17_1
  doi: 10.2147/CMAR.S248698
– ident: e_1_2_9_35_1
  doi: 10.1007/s13577-022-00725-1
– volume-title: The Newcastle‐Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta‐Analyses
  year: 2000
  ident: e_1_2_9_16_1
– ident: e_1_2_9_18_1
  doi: 10.1016/j.yexmp.2020.104451
– ident: e_1_2_9_63_1
  doi: 10.3892/or.2020.7897
– ident: e_1_2_9_83_1
  doi: 10.1002/cac2.12108
– ident: e_1_2_9_14_1
  doi: 10.1155/2017/7243968
– ident: e_1_2_9_71_1
  doi: 10.3390/cells9020276
– ident: e_1_2_9_75_1
  doi: 10.1016/S0140-6736(16)32407-2
– ident: e_1_2_9_41_1
  doi: 10.1016/j.arcmed.2022.01.004
– ident: e_1_2_9_65_1
  doi: 10.1093/abbs/gmz114
– ident: e_1_2_9_40_1
  doi: 10.2147/CMAR.S284258
– volume-title: StatPearls Publishing Copyright © 2022
  year: 2022
  ident: e_1_2_9_2_1
– ident: e_1_2_9_19_1
  doi: 10.1371/journal.pone.0105382
– ident: e_1_2_9_47_1
  doi: 10.1093/carcin/bgab013
– ident: e_1_2_9_54_1
  doi: 10.1007/s10238-015-0396-8
– ident: e_1_2_9_55_1
  doi: 10.7150/ijms.51329
– ident: e_1_2_9_74_1
  doi: 10.18632/oncotarget.17303
– ident: e_1_2_9_4_1
  doi: 10.3324/haematol.2020.274258
– ident: e_1_2_9_34_1
  doi: 10.18632/oncotarget.20053
– ident: e_1_2_9_13_1
  doi: 10.1016/j.critrevonc.2019.05.007
– ident: e_1_2_9_59_1
  doi: 10.3390/cells11213394
– ident: e_1_2_9_10_1
  doi: 10.1371/journal.pone.0138236
– ident: e_1_2_9_58_1
  doi: 10.7150/jca.60521
– ident: e_1_2_9_44_1
  doi: 10.1080/08923973.2022.2052896
– ident: e_1_2_9_48_1
  doi: 10.1016/j.lfs.2019.03.040
– ident: e_1_2_9_79_1
  doi: 10.3892/ijo.2021.5274
– ident: e_1_2_9_42_1
  doi: 10.1007/s13273-022-00237-x
– ident: e_1_2_9_72_1
  doi: 10.1007/978-981-10-5203-3_1
– ident: e_1_2_9_25_1
  doi: 10.1002/hon.3004
– ident: e_1_2_9_85_1
  doi: 10.1016/j.lfs.2021.119932
– ident: e_1_2_9_23_1
  doi: 10.1038/s41419-019-1479-3
– ident: e_1_2_9_43_1
  doi: 10.2147/OTT.S249429
– ident: e_1_2_9_45_1
  doi: 10.1186/s12935-020-1158-6
– ident: e_1_2_9_50_1
  doi: 10.1002/jcla.24168
– ident: e_1_2_9_22_1
  doi: 10.1038/s41419-019-1886-5
– ident: e_1_2_9_37_1
  doi: 10.3892/etm.2022.11564
– ident: e_1_2_9_68_1
  doi: 10.1042/EBC20200032
– ident: e_1_2_9_3_1
  doi: 10.1007/s10552-019-01155-5
– ident: e_1_2_9_88_1
  doi: 10.18632/oncotarget.15711
– ident: e_1_2_9_76_1
  doi: 10.1016/j.cca.2019.04.082
– volume: 2021
  start-page: 1
  year: 2021
  ident: e_1_2_9_56_1
  article-title: TUC338 promotes diffuse large B cell lymphoma growth via regulating EGFR/PI3K/AKT signaling pathway
  publication-title: J Oncol
– ident: e_1_2_9_5_1
  doi: 10.1016/j.transci.2013.05.029
– ident: e_1_2_9_32_1
  doi: 10.1016/j.biopha.2015.12.001
– ident: e_1_2_9_73_1
  doi: 10.1158/0008-5472.CAN-10-2483
– ident: e_1_2_9_26_1
  doi: 10.1080/10428194.2021.1876866
– ident: e_1_2_9_15_1
  doi: 10.1371/journal.pmed.1000097
– ident: e_1_2_9_7_1
  doi: 10.1038/cr.2014.165
– ident: e_1_2_9_57_1
  doi: 10.1002/cbin.11327
– ident: e_1_2_9_61_1
  doi: 10.18632/oncotarget.17956
– ident: e_1_2_9_82_1
  doi: 10.1038/onc.2017.184
– ident: e_1_2_9_53_1
  doi: 10.3892/ol.2020.12300
– ident: e_1_2_9_70_1
  doi: 10.1073/pnas.242606799
– ident: e_1_2_9_39_1
  doi: 10.1002/jcla.24680
– ident: e_1_2_9_21_1
  doi: 10.1016/j.bbrc.2019.01.105
– ident: e_1_2_9_30_1
  doi: 10.1007/s10238-015-0350-9
– ident: e_1_2_9_86_1
  doi: 10.1002/jbt.22768
– ident: e_1_2_9_84_1
  doi: 10.1038/s41417-020-00267-4
– ident: e_1_2_9_11_1
  doi: 10.1016/j.biopha.2017.02.011
– ident: e_1_2_9_51_1
  doi: 10.1007/s11010-021-04335-7
– ident: e_1_2_9_67_1
  doi: 10.1073/pnas.1505753112
– ident: e_1_2_9_64_1
  doi: 10.1186/s12967-016-1100-9
– ident: e_1_2_9_24_1
  doi: 10.18632/oncotarget.15571
– ident: e_1_2_9_66_1
  doi: 10.12659/MSM.912141
– ident: e_1_2_9_29_1
  doi: 10.3892/mmr.2016.5190
– ident: e_1_2_9_77_1
  doi: 10.1056/NEJMra0807082
– ident: e_1_2_9_27_1
  doi: 10.1016/j.humgen.2022.201112
– ident: e_1_2_9_31_1
  doi: 10.12659/MSM.922810
– volume: 25
  start-page: 2567
  issue: 6
  year: 2021
  ident: e_1_2_9_52_1
  article-title: LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR‐508‐3p/NFIB axis in diffuse large B‐cell lymphoma
  publication-title: Eur Rev Med Pharmacol Sci
– ident: e_1_2_9_49_1
  doi: 10.1007/s10238-021-00748-2
– ident: e_1_2_9_38_1
  doi: 10.1111/jcmm.14601
– ident: e_1_2_9_62_1
  doi: 10.2147/CMAR.S233859
– ident: e_1_2_9_8_1
  doi: 10.1007/s00335-021-09939-4
– ident: e_1_2_9_36_1
  doi: 10.1038/s41420-022-00819-7
– volume: 11
  start-page: 56
  issue: 1
  year: 2021
  ident: e_1_2_9_6_1
  article-title: Long non‐coding RNAs and their potential roles in the vector‐host‐pathogen triad
  publication-title: Life (Basel, Switzerland)
– ident: e_1_2_9_78_1
  doi: 10.1093/biohorizons/hzt006
– ident: e_1_2_9_69_1
  doi: 10.1248/yakushi.20-00002
– ident: e_1_2_9_9_1
  doi: 10.1038/s41392-023-01342-6
– ident: e_1_2_9_87_1
  doi: 10.3389/fimmu.2022.813031
– ident: e_1_2_9_33_1
  doi: 10.1016/j.biopha.2016.02.032
– ident: e_1_2_9_81_1
  doi: 10.3892/or.2017.5821
– ident: e_1_2_9_12_1
  doi: 10.18632/oncotarget.16163
– volume: 102
  start-page: 824
  year: 2017
  ident: e_1_2_9_20_1
  article-title: Microarray expression profile of long noncoding RNAS in germinal center‐like diffuse large B‐cell lymphoma
  publication-title: Haematologica
– ident: e_1_2_9_28_1
  doi: 10.1038/s41598-021-81715-5
– ident: e_1_2_9_46_1
  doi: 10.3233/CBM-160221
SSID ssj0036139
Score 2.4573503
SecondaryResourceType review_article
Snippet Cancer initiation and progression have been associated with dysregulated long non‐coding RNA (lncRNA) expression. However, the lncRNA expression profile in...
Cancer initiation and progression have been associated with dysregulated long non-coding RNA (lncRNA) expression. However, the lncRNA expression profile in...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1928
SubjectTerms Adult
aggressive non‐Hodgkin lymphoma
Apoptosis
B-cell lymphoma
biomarker
Biomarkers
Burkitt Lymphoma - drug therapy
Burkitt's lymphoma
Cell cycle
Cell migration
Cell proliferation
Chemotherapy
Cyclin-dependent kinases
Diagnosis
diffuse large B‐cell lymphoma
Epigenetics
Growth factors
Humans
Kinases
Leukemia
long non‐coding RNA
Lymphocytes
Lymphocytes B
Lymphoma
Lymphoma, Large B-Cell, Diffuse - diagnosis
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoma, Large B-Cell, Diffuse - genetics
Lymphoma, Mantle-Cell
Mantle cell lymphoma
Non-coding RNA
Non-Hodgkin's lymphoma
non‐Hodgkin lymphomas
Pathogenesis
Prognosis
Proteins
Review
Reviews
RNA, Long Noncoding - genetics
Systematic review
Therapeutic applications
Therapeutic targets
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS-QwEB_8QPBF1Du1fhE5X06obJt0mwgiqyiLuD4ct-BbSZPpurh2df3Afbm__SZtt7oovpVkmqYzmc5v0skMwL5AHqJJjc8xM74IU0UqhejrkBurpIkbqdvQ71w3211xeRPdzMCkfmfFwKcvXTtXT6o7Ghy-PY5PSOGP66gcc39_GMSximZhnixS7BS0I-q_CZxMlqpSk07TTxujTwjzc6DkRwBbWKCLZViqoCNrlbJegRnMV2GhLCY5_gH_roZ5j5E375uhM0jsz3WL6Semqe0VB8wdtHexOCOmc8s-nLtiZTQ46-dM9wr3m76A7NR3e_rFeO2h7d1R72BMoqdBjliLvWeAZuXpl5_QvTj_e9b2q-oKvhHkFfkYhlpxhTLCVOtmKo20EhWXWagy166DNGhwJH9JGwy4VYFwyQltikoL2-RrMEdzwA1gaLMoiowr5EPsz6zGpqEbjAyEtTKSHvyesDkxVepxVwFjkNQuCIkkKUTiwa-a9qFMuPEl1fZEWslkzSSElAifKXIJPdiru0ldHL90jsMXRxM2OCeUFXiwXgq3fgyPQ-Hy4Xsgp8ReE7hU3NM9ef-2SMlNjOKKwLYHB8UK-WbqyeVZp1NcbX7_Eluw6Grbl7HB2zD3PHrBHUJAz-lusbz_AyzgCQE
  priority: 102
  providerName: Scholars Portal
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1faxQxEB9qRfBF_O_WKhF9UVi5TbJ3ifhyFstRvCJioW9LNpk9i9u90muFvvniux_Bz-JH8ZM4k91b76gIvi3JbHbJZJLfhJnfADzTqCT60qcKK59qWVoyKcTUSeWDNX40KPlCf7o_nBzovcP8cANeL3NhWn6I_sKNLSPu12zgrlysGrk_Pn6ZjUY2vwJXObeWmfOlfr_chxUdVDaypRKGpIVrOnLSGMfTv7t-HF3CmJdDJVchbDyDdm_CjQ48inGr7Vuwgc1tuNaWk7y4A9_ezZuZIH_-19fvfs6HkviwPxZuIRy1fsFacLI9x-OcCtcEsZJ7JdqIcHHUCDeLLjjtguIND4R13Y05mYfZZ5KoL2gJ0ECvxPjnjz9U0KJNg7kLB7tvP-5M0q7MQuo1uUcpSumssmhyLJ0blsabYNAqU0lbcbvLymygkBwn5zFTwWaaWQpDidbpMFT3YJN-Ax-AwFDlee65og8hgyo4HHp6wZtMh2Byk8Dz5WwXvuMg51IYddH7IqSZImomgae97EnLvPFXqe2l0orO-hYFQSYCapZ8wwSe9N1kNzxlrsH5OcvIgVIEt7IE7rc67j-jRlIzMX4CZk37vQBzcq_3NEefIjc3TZSyhLoTeBEXyj9-vdjbmU7j09b_CD-E61zyvg0Z3obNs9NzfETA6Kx8HNf_b0cWEIg
  priority: 102
  providerName: Wiley-Blackwell
Title Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjcmm.17795
https://www.ncbi.nlm.nih.gov/pubmed/37246627
https://www.proquest.com/docview/2836159619
https://www.proquest.com/docview/2820336351
https://pubmed.ncbi.nlm.nih.gov/PMC10339099
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-xTUi8IL4XGJURvIBkaGKnsXlB3bSpmmg1TRRVvESO7ZSJLhnrhrQX_nbunDTrNLSXJPJXHJ_t-8j5dwDvpBeJt4XlwpeWy6TQuKS85yYR1mlls35BBv3xZDCaysNZOmsNbsvWrXK1J4aN2tWWbOSfkA0i89Uo7385-80pahT9XW1DaGzAFkGXkUtXNusULqwgdAtJGrx37OnpxzjLKJbEOhO6JVnedpBcF1wD5zl4BA9bkZENGxo_hnu-egL3myCSV0_h79e6mjPU4rmtiRGx48mQmSUzmPbHLxgdsCcfnHNmKsfWzluxxgucnVTMzIPajTsf2-Vkyw_tjWo3_4W5iyskOTbymQ3ZNfIza069PIPpwf63vRFvoypwK1Eb4j5JjBbaq9QXxgwKZZVTXgtVJrqkdBMXcV941JOM9bFwOpYESugKr410A_EcNrEPfhuYd2WappYC-KAgUDrjBxYrWBVL51SqIni_GubctpDjFPlikXeqB5IkDySJ4G1X9qwB2vhvqZ0VtfJ2sS3z66kRwZsuG5cJjZepfH1JZZK-EChdxRG8aIjbvUZkiSQc_AjUDbJ3BQiC-2ZOdfIzQHHjQAmNQnYEH8IMuaPr-eHeeByeXt79Ea_gAcW0b3yCd2Dz4vzSv0bJ56LowUYij3phkvdga_h9-mOK9939ydFxL1gT8DqW6h-08wzZ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9swED-xoml7mfZNNrZ52vawSRmNnRQbCU2FgQq01YRA4i049qVDKwmjsKkv_En7GznnCyom3niLbMdxfGff7-z7APgYouBoEuMLTI0f8kTRkkL0NRfGKmmW24k70B8MO739cPsgOpiDf7UvjDOrrPfEYqO2uXFn5EskBkn4KsL7305--y5rlLtdrVNolGyxg9O_pLJNVre-E30_cb65sbfe86usAr4JSRvwkXOthEIZYaJ1J5FGWolKyJSr1JXrIAnaAklP0AYDYVUQuqB8NkGlQ9sR1O89mA8FqTItmF_bGP7Yrfd-GqJQVRDUwl7IHB9_DejtaFbs3cCyN00yr0PlQtZtPoZHFUhl3ZKrnsAcZk_hfpm2cvoMLvp5NmJZnvkmd6KP7Q67TE-YprI_OGbOpd9Z_ZwynVl2zcOLlXbn7ChjelQo-rTXsjXf3R4U_fVyO_pFteMpMRl1ssK67CrWNCv9bJ7D_p3M-Ato0RhwARjaNIoi41IGEfRIrcaOoReMDEJrZSQ9-FxPc2yqIOcu18Y4bpQdIklckMSDD03bkzK0x39bLdbUiqvlPYmvmNGD9001LUw3XzrD_Ny14W0hCM8FHrwsidt8Rizz0EXe90DOkL1p4IJ-z9ZkRz-L4N80UUIRrPfgS8Ehtww93l4fDIqnV7f_xDt40Nsb9OP-1nDnNTzkhONKi-RFaJ2dnuMbwl1nyduK2Rkc3vX6ugRRsUVc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIRAviG8CA4yAB5DCGjtpbSSEykbVfbRCiEl9C459KRNdMtYN1Bf-MP46zs7HVg3tbW-R7TiO7873O_t8B_AyRsHRZCYUmJsw5pkikUIMNRfGKml6ncxt6I_G3eFevD1JJivwt7kL49wqmzXRL9S2NG6PfJ3UIClfRXh_Pa_dIj5vDj4c_gxdBil30tqk06hYZAcXv8l8m7_f2iRav-J88OnrxjCsMwyEJibLIETOtRIKZYKZ1t1MGmklKiFzrnJXrqMs6ggkm0EbjIRVUewC9NkMlY5tV1C_V-BqTySRk7HepDX2aLBC1eFQveeQOTh4G9G7ybICPIdqzztnngXNXusNbsHNGq6yfsVft2EFiztwrUpgubgLf3bLYsqKsghN6ZQg-zLuMz1nmsp-4Yy5y_3O_-eI6cKyM3e9WOWBzvYLpqfe5KdVl30M3TmC729Y2ukPqp0tiN2ok3esz06jTrPqxs092LuU-b4PqzQGfAgMbZ4kiXHJgwiE5FZj19ALRkaxtTKRAbxupjk1dbhzl3VjlrZmD5Ek9SQJ4EXb9rAK8vHfVmsNtdJa0OfpKVsG8LytJhF186ULLE9cG94RgpBdFMCDirjtZ0SPxy4GfwByiextAxf-e7mm2P_uw4DTRAlFAD-AN55DLhh6ur0xGvmnRxf_xDO4TlKV7m6Ndx7DDU6ArnJNXoPV46MTfEIA7Dh76jmdwbfLFq1_qO9ILA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long+non-coding+RNA+as+a+novel+biomarker+and+therapeutic+target+in+aggressive+B-cell+non-Hodgkin+lymphoma%3A+A+systematic+review&rft.jtitle=Journal+of+cellular+and+molecular+medicine&rft.au=Khanmohammadi%2C+Shaghayegh&rft.au=Fallahtafti%2C+Parisa&rft.date=2023-07-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.eissn=1582-4934&rft.volume=27&rft.issue=14&rft.spage=1928&rft.epage=1946&rft_id=info:doi/10.1111%2Fjcmm.17795&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1582-1838&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1582-1838&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1582-1838&client=summon